Levamisole and/or Chinese medicinal herbs can modulate the serum level of squamous cell carcinoma associated antigen in patients with erosive oral lichen planus

Journal of Oral Pathology and Medicine

Volumn 30, Issue 9, 2001, Pages 542-8

  Sun, A ^a   Chiang, C P ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Chinese medicinal herbs; Erosive oral lichen planus; Levamisole; Squamous cell carcinoma associated antigen

Indexed keywords

APHTHOUS STOMATITIS; BEHCET DISEASE; BIOLOGICAL MARKER; CHINA; CONCENTRATION (PARAMETERS); LEUKOPLAKIA; LEVAMISOLE; LICHEN PLANUS; MEDICINAL PLANT; ORAL SQUAMOUS CELL CARCINOMA; ORAL SUBMUCUS FIBROSIS; SERODIAGNOSIS;

EID: 0034784584     PISSN: 09042512     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0714.2001.300906.x     Document Type: Article

References (32)

1. Oral lichen planus: A demographic study
2. A review of the recent literature regarding malignant transformation of oral lichen planus
3. Response to levamisole and low-dose prednisolone in 41 patients with chronic oral ulcers - A 3-year open clinical trial and follow-up study
4. Clinical response to levamisole in thirty-nine patients with erythema multiforme: An open prospective study
5. Comparative study of the clinical efficacy of four DMARDs (leflunomide, methotrexate, cyclosporine, and levamisole) in patients with rheumatoid arthritis
6. Cellular immune modulation after a single high dose of levamisole in patients with carcinoma
7. The levamisole story
8. Potentiation of interleukin-2 activity by levamisole and imidazole
9. Immunomodulation by levamisole in patients with recurrent aphthous ulcers or oral lichen planus
10. Presence of anti-basal cell antibodies in oral lichen planus
11. Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma
12. Tumor-associated antigen, TA-4, in the monitoring of the effects of therapy for squamous cell carcinoma of the uterine cervix
13. Value of tumor-antigen (TA-4) of squamous cell carcinoma in predicting the extent of cervical cancer
14. Pretreatment tumour-antigen Ta-4 in serum of patients with squamous cell carcinoma of the uterine cervix
15. Prognostic significance of the tumor antigen TA.4 in squamous cell carcinoma of the uterine cervix
16. An evaluation of squamous cell carcinoma antigen in patients with cervical squamous cell carcinoma
17. Tumor antigen of human cervical squamous cell carcinoma
18. Availability of tumor-antigen 4 as a marker of squamous cell carcinoma of the lung and other organs
19. Usefulness of squamous cell carcinoma antigen (SCC) in carcinoma of the esophagus
20. Soluble immune complexes and squamous cell carcinoma-related antigens in patients with head and neck cancer
21. Squamous cell carcinoma antigen as a marker for squamous cell carcinoma of the anal canal
22. Significance of squamous cell carcinoma (SCC)-related antigens in cutaneous SCC
23. Oral lichen planus and squamous carcinoma: Case report and update of the literature
24. Malignant development of lichen planus-affected oral mucosa
25. Oral lichen planus and its association with squamous cell carcinoma: An update on pathogenesis and treatment implications
26. Criteria for diagnosis of Behçet's syndrome
27. In vitro release of a tumor-antigen (TA-4) by human cervical squamous cell carcinoma
28. Tumor-antigen 4: Its immunohistochemical distribution and tissue and serum concentrations in squamous cell carcinoma of the lung and esophagus